Juno Therapeutics (JUNO) Stock: Here’s What You Need To Know

Juno Therapeutics (NASDAQ: JUNO) On July 12, 2016 it was announced that the FDA had released the clinical hold for the company’s lead drug candidate ¬†JCAR015. A few weeks prior the FDA had put Juno’s trial, known as ROCKET, on a clinical hold because there were two patient deaths in the trial. The company proclaimed … Read more